Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Spero Therapeutics (SPRO) Other Operating Expenses (2023 - 2025)

Historic Other Operating Expenses for Spero Therapeutics (SPRO) over the last 2 years, with Q3 2025 value amounting to $587000.0.

  • Spero Therapeutics' Other Operating Expenses changed N/A to $587000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $587000.0, marking a year-over-year change of. This contributed to the annual value of $5.3 million for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Spero Therapeutics' Other Operating Expenses is $587000.0.
  • Spero Therapeutics' Other Operating Expenses' 5-year high stood at $5.3 million during Q3 2023, with a 5-year trough of $587000.0 in Q3 2025.